Community-reported Tegretol side effects:
Add Your Side Effect to the Community Database
Help Community - Describe Your Tegretol Side Effect Episode
Have You dealt with a Tegretol side effect? Share your experience
Review Tegretol Safety Reports submitted to FDA
Total Tegretol reports: 685.Tegretol FDA safety alerts: 2005 2007 2008 .
Reported deaths: 40 Reported hospitalizations: 304.
Take Tegretol Side Effects Survey, Discuss Tegretol with others
FDA Reported Tegretol Side Effects: convulsion, aspartate aminotransferase increased, alanine aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, somnolence, gamma-glutamyltransferase increased, headache, loss of consciousness, fall, vomiting.
Tegretol Usage.
If you have questions about Tegretol, you can ask a Health Expert or Ask Patient Community about Tegretol.
< Previous Showing 301-400 of 685 Next >
Tegretol Side Effects Report #5040725-0Physician from COLOMBIA reported TEGRETOL problem on June 22, 2006. Female patient, 48 years of age, weighting 180.8 lb, was diagnosed with epilepsy, hypertension and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: activities of daily living impaired, asthenia, flushing, malaise, mouth ulceration. TEGRETOL dosage: 200 MG, QD. During the same period patient was treated with LOSARTAN, HYDROCHLOROTHIAZIDE. Patient recovered.
Tegretol Side Effects Report #5040726-2
TEGRETOL problem was reported by a Pharmacist from UNITED KINGDOM on June 20, 2006. Female patient was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: poor weight gain neonatal. TEGRETOL dosage: unknown. Patient recovered.
Tegretol Side Effects Report #5042336-X
Consumer or non-health professional from GERMANY reported TEGRETOL problem on June 02, 2006. Male patient, 47 years of age, was diagnosed with convulsion and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: aggression, cardiac arrest, coma, epilepsy. TEGRETOL dosage: 400 MG, BID. During the same period patient was treated with DOGMATILTE. Patient recovered.
Tegretol Side Effects Report #5042341-3
TEGRETOL problem was reported by a Consumer or non-health professional from GERMANY on June 26, 2006. Female patient was diagnosed with simple partial seizures and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: intraocular pressure increased, optic atrophy, visual disturbance, visual field defect. TEGRETOL dosage: 400 MG/DAY. During the same period patient was treated with BISOPROLOL FUMARATE, LEXOTANIL. Patient recovered.
Tegretol Side Effects Report #5042344-9
Pharmacist from JAPAN reported TEGRETOL problem on June 28, 2006. Male patient, 53 years of age, was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: cerebral atrophy. TEGRETOL dosage: unknown. Patient recovered.
Tegretol Side Effects Report #5043622-X
TEGRETOL problem was reported by a Consumer or non-health professional from UNITED STATES on June 28, 2006. Female patient, 22 years of age, weighting 181.9 lb, was diagnosed with convulsion and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, haematuria, urine analysis abnormal. TEGRETOL dosage: 400 MG, BID. During the same period patient was treated with LAMICTAL, FOLIC ACID, SELENIUM SULFIDE. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5043625-5
Consumer or non-health professional from JAPAN reported TEGRETOL problem on June 28, 2006. Male patient, 68 years of age, was diagnosed with trigeminal neuralgia and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: depressed level of consciousness. TEGRETOL dosage: 1400 MG/DAY. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5043626-7
TEGRETOL problem was reported by a Consumer or non-health professional from FRANCE on June 26, 2006. Female patient was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: abortion induced, trisomy 21, ventricular hypoplasia. TEGRETOL dosage: 200 MG/DAY. During the same period patient was treated with DEPAKENE, RIVOTRIL. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5044807-9
Health Professional from SWITZERLAND reported TEGRETOL problem on Nov 07, 2005. Female patient, 90 years of age, was diagnosed with trigeminal neuralgia, hypertension and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: blood pressure systolic increased, cardiac failure, hypertension, ventricular hypertrophy. TEGRETOL dosage: 200 MG, BID. During the same period patient was treated with THIAZIDES, CALCIUM CHANNEL BLOCKERS, ACE INHIBITORS AND DIURETICS, PHYSIOTENS, ATACAND, ATACAND HCT, CARVEDILOL, TORASEMIDE. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5045325-4
TEGRETOL problem was reported by a Consumer or non-health professional from BRAZIL on June 27, 2006. Female patient, 51 years of age, weighting 119.0 lb, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: amnesia, angina pectoris, chest pain, convulsion, disturbance in attention, haemangioma of liver, insomnia, memory impairment, menopausal symptoms. TEGRETOL dosage: 200 MG, BID. Patient recovered.
Tegretol Side Effects Report #5047444-5
Consumer or non-health professional from BRAZIL reported TEGRETOL problem on July 04, 2006. Male patient, 37 years of age, weighting 160.9 lb, was diagnosed with bipolar disorder and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: acne, furuncle, rash macular, skin exfoliation. TEGRETOL dosage: 200 MG, BID. During the same period patient was treated with LITHIUM CARBONATE. Patient recovered.
Tegretol Side Effects Report #5047593-1
TEGRETOL problem was reported by a Physician from GERMANY on Apr 27, 2005. Female patient, 48 years of age, was diagnosed with epilepsy, metastases to bone and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: actinomycosis, bone disorder, dental operation, excessive granulation tissue, impaired healing, malignant neoplasm progression, mucosal ulceration, oedema mucosal, oral surgery. TEGRETOL dosage: unknown. During the same period patient was treated with LAMICTAL, ZOMETA. Patient recovered.
Tegretol Side Effects Report #5050025-0
Physician from JAPAN reported TEGRETOL problem on Mar 20, 2006. Male patient, 45 years of age, weighting 132.3 lb, was diagnosed with schizophrenia and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, convulsion, eosinophil count increased, erythema, human herpes virus 6 serology positive, lip erosion, lymphadenopathy. TEGRETOL dosage: 100 MG, TID. During the same period patient was treated with CONTOMIN, AKINETON. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5051065-8
TEGRETOL problem was reported by a Physician from DENMARK on July 04, 2006. Male patient, 18 years of age, was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: sperm count decreased, testis cancer. TEGRETOL dosage: unknown. Patient recovered.
Tegretol Side Effects Report #5051066-X
Consumer or non-health professional from FRANCE reported TEGRETOL problem on July 10, 2006. Male patient, 71 years of age, was diagnosed with facial neuralgia and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: asthenia, bacteria urine, beta 2 microglobulin increased, dysaesthesia, granulocyte count increased, inflammation, leukocytosis, night sweats. TEGRETOL dosage: unknown. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5051067-1
TEGRETOL problem was reported by a Physician from JAPAN on June 15, 2006. Male patient, weighting 123.5 lb, was diagnosed with diabetic neuropathy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: arrhythmia, arteriosclerosis, blood alkaline phosphatase increased, blood glucose increased, blood lactate dehydrogenase increased, bronchitis chronic, c-reactive protein increased, chest discomfort. TEGRETOL dosage: 200 MG/DAY. During the same period patient was treated with ASPIRIN, ACTOS, EUGLUCON, PRAVASTATIN. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5051068-3
Physician from UNITED KINGDOM reported TEGRETOL problem on July 04, 2006. Female patient, child 6 years of age, was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: accidental exposure, coma, loss of consciousness. TEGRETOL dosage: unknown. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5051070-1
TEGRETOL problem was reported by a Consumer or non-health professional from JAPAN on June 28, 2006. Male patient, 68 years of age, was diagnosed with trigeminal neuralgia and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: glasgow coma scale abnormal, loss of consciousness, rash, varicella. TEGRETOL dosage: 1400 MG. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5051071-3
Consumer or non-health professional from CHINA reported TEGRETOL problem on July 10, 2006. Female patient, 28 years of age, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: caesarean section, normal newborn. TEGRETOL dosage: 400 MG/DAY. Patient recovered.
Tegretol Side Effects Report #5051079-8
TEGRETOL problem was reported by a Consumer or non-health professional from FRANCE on July 10, 2006. Female patient, 38 years of age, was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: genital pruritus female, genital ulceration, lactobacillus infection, mouth ulceration, rash erythematous, rash maculovesicular, toxic skin eruption. TEGRETOL dosage: 500 MG, QD. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5052402-0
Consumer or non-health professional from BRAZIL reported TEGRETOL problem on June 27, 2006. Female patient, 51 years of age, weighting 119.0 lb, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: amnesia, angina pectoris, chest pain, convulsion, disturbance in attention, haemangioma of liver, insomnia, memory impairment, menopausal symptoms. TEGRETOL dosage: 200 MG, BID. Patient recovered.
Tegretol Side Effects Report #5052403-2
TEGRETOL problem was reported by a Physician from JAPAN on July 10, 2006. Male patient was diagnosed with trigeminal neuralgia and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: abscess neck, agranulocytosis, tonsillitis. TEGRETOL dosage: 600 MG/DAY. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5053115-1
Health Professional from FRANCE reported TEGRETOL problem on July 04, 2006. Male patient, 65 years of age, was diagnosed with hypercholesterolaemia, diabetes mellitus, cerebrovascular accident and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, eosinophilia, face oedema, gamma-glutamyltransferase increased, prothrombin time shortened, rash pruritic. TEGRETOL dosage: 800 MG. During the same period patient was treated with NEXIUM, PRAVASTATIN, DIAMICRON, PLAVIX. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5053366-6
TEGRETOL problem was reported by a Physician from JAPAN on June 28, 2006. Male patient, 53 years of age, was diagnosed with temporal lobe epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: cerebral atrophy, computerised tomogram abnormal, nuclear magnetic resonance imaging abnormal. TEGRETOL dosage: 300 MG/DAY. Patient recovered.
Tegretol Side Effects Report #5053367-8
Pharmacist from JAPAN reported TEGRETOL problem on Mar 28, 2006. Male patient, child 11 years of age, weighting 74.96 lb, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, convulsion. TEGRETOL dosage: 100 MG, BID. Patient recovered.
Tegretol Side Effects Report #5053368-X
TEGRETOL problem was reported by a Consumer or non-health professional from JAPAN on July 12, 2006. Male patient, 57 years of age, was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: disseminated intravascular coagulation. TEGRETOL dosage: unknown. Patient recovered.
Tegretol Side Effects Report #5055347-5
Consumer or non-health professional from UNITED STATES reported TEGRETOL problem on July 18, 2006. Female patient, 46 years of age, weighting 138.0 lb, was diagnosed with convulsion and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: cerebral palsy, convulsion, dehydration. TEGRETOL dosage: 40 MG BID PO. During the same period patient was treated with DILANTIN, DEPAKOTE. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5055793-X
TEGRETOL problem was reported by a Pharmacist from CANADA on July 14, 2006. Female patient, 28 years of age, was diagnosed with neuralgia and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: galactorrhoea. TEGRETOL dosage: 200 MG. Patient recovered.
Tegretol Side Effects Report #5059822-9
Consumer or non-health professional from GERMANY reported TEGRETOL problem on Apr 26, 2006. Male patient was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, convulsion, dermatitis allergic, fatigue, rash, rash pustular, skin haemorrhage, stomach discomfort, testicular neoplasm. TEGRETOL dosage: unknown. During the same period patient was treated with PERENTEROL, LUMINAL, RIVOTRIL. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5060597-8
TEGRETOL problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 21, 2006. Female patient, 45 years of age, was diagnosed with epilepsy, psychotic disorder, depression, contraception and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: weight increased. TEGRETOL dosage: 600 MG/DAY. During the same period patient was treated with ABILIFY, CITALOPRAM HYDROBROMIDE, KEMADRIN, KEPPRA, FEMODENE, SOLIAN. Patient died on 06/10/2006.
Tegretol Side Effects Report #5060609-1
Consumer or non-health professional from UNITED STATES reported TEGRETOL problem on Oct 30, 2005. Male patient, 42 years of age, was diagnosed with complex partial seizures and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: back pain, osteopenia, spinal fracture, urine calcium increased. TEGRETOL dosage: unknown. Patient recovered.
Tegretol Side Effects Report #5060647-9
TEGRETOL problem was reported by a Consumer or non-health professional from GERMANY on Feb 27, 2006. Female patient was diagnosed with grand mal convulsion and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: adrenocortical insufficiency acute, aura, blood corticotrophin abnormal, blood sodium decreased, dehydroepiandrosterone decreased, depression, dyspnoea, eyelid function disorder, gamma-glutamyltransferase increased. TEGRETOL dosage: 400 MG/DAY. During the same period patient was treated with CONTRACEPTIVES UNS, KEPPRA. Patient recovered.
Tegretol Side Effects Report #5061690-6
Consumer or non-health professional from FRANCE reported TEGRETOL problem on July 18, 2006. Male patient, 22 years of age, was diagnosed with partial seizures, pain and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: chest pain, convulsion, depressed level of consciousness, fall, glasgow coma scale abnormal, headache, toothache. TEGRETOL dosage: unknown. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5063035-4
TEGRETOL problem was reported by a Consumer or non-health professional from JAPAN on July 12, 2006. Male patient, 57 years of age, was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: disseminated intravascular coagulation. TEGRETOL dosage: unknown. Patient recovered.
Tegretol Side Effects Report #5063044-5
Consumer or non-health professional from reported TEGRETOL problem on July 13, 2006. Male patient, child 10 years of age, was diagnosed with cerebral disorder, dermatitis atopic and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: burning sensation, dermatitis atopic, dyskinesia, headache, nausea, pruritus, skin haemorrhage, somnolence. TEGRETOL dosage: 7 ML/DAY. During the same period patient was treated with ELIDEL, TRILEPTAL, KETOTIFEN. Patient recovered.
Tegretol Side Effects Report #5064312-3
TEGRETOL problem was reported by a Pharmacist from UNITED KINGDOM on July 20, 2006. Female patient was diagnosed with diabetic neuropathy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: convulsion. TEGRETOL dosage: unknown. Patient recovered.
Tegretol Side Effects Report #5064314-7
Consumer or non-health professional from reported TEGRETOL problem on July 13, 2006. Male patient, child 10 years of age, was diagnosed with cerebral disorder and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: burning sensation, dermatitis atopic, dyskinesia, headache, nausea, pruritus, skin haemorrhage, somnolence. TEGRETOL dosage: 7 ML/DAY. During the same period patient was treated with ELIDEL, TRILEPTAL, KETOTIFEN. Patient recovered.
Tegretol Side Effects Report #5064778-9
TEGRETOL problem was reported by a Physician from JAPAN on Apr 27, 2006. Male patient, 33 years of age, weighting 108.0 lb, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, arrhythmia, aspartate aminotransferase increased, blood calcium decreased, blood creatine phosphokinase increased, blood phosphorus increased, blood potassium decreased, blood sodium decreased. TEGRETOL dosage: 6000 MG, ONCE/SINGLE. During the same period patient was treated with ALEVIATIN. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5066011-0
Pharmacist from UNITED STATES reported TEGRETOL problem on July 31, 2006. Male patient, 22 years of age, was diagnosed with grand mal convulsion, tremor and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: abdominal pain, back pain, chest pain, liver function test abnormal, musculoskeletal chest pain. TEGRETOL dosage: 800 MG BID PO, AT LEAST 2 YRS AGO. During the same period patient was treated with NEURONTIN. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5066230-3
TEGRETOL problem was reported by a Consumer or non-health professional from GERMANY on May 02, 2006. Male patient was diagnosed with grand mal convulsion and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: azoospermia, infertility male, memory impairment, mobility decreased, petit mal epilepsy. TEGRETOL dosage: 600-0-600 MG/DAY. Patient recovered.
Tegretol Side Effects Report #5066234-0
Consumer or non-health professional from JAPAN reported TEGRETOL problem on July 26, 2006. Female patient, 41 years of age, was diagnosed with convulsion and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: cytomegalovirus viraemia, enteritis infectious, liver disorder, multi-organ failure, rash. TEGRETOL dosage: unknown. During the same period patient was treated with VALPROATE, ZONISAMIDE. Patient died.
Tegretol Side Effects Report #5069226-0
TEGRETOL problem was reported by a Physician from JAPAN on July 03, 2006. Female patient, 60 years of age, was diagnosed with trigeminal neuralgia and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, anaemia, haemoglobin decreased, malaise, neutrophil percentage decreased, platelet count decreased, pyelonephritis, pyrexia, white blood cell count decreased. TEGRETOL dosage: unknown. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5069228-4
Pharmacist from JAPAN reported TEGRETOL problem on July 05, 2006. Female patient, 39 years of age, weighting 116.8 lb, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: delayed delivery, normal newborn, uterine haemorrhage, vacuum extractor delivery. TEGRETOL dosage: 400 MG/DAY. During the same period patient was treated with FOLIAMIN. Patient recovered.
Tegretol Side Effects Report #5069229-6
TEGRETOL problem was reported by a Physician from JAPAN on July 10, 2006. Male patient, 68 years of age, weighting 127.9 lb, was diagnosed with trigeminal neuralgia and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: abscess drainage, abscess neck, agranulocytosis, alanine aminotransferase increased, blood alkaline phosphatase increased, haematocrit decreased, haemoglobin decreased, headache, lymphocyte count increased. TEGRETOL dosage: 600 MG/DAY. During the same period patient was treated with FINIBAX, PRODIF, IMMUNE GLOBULIN INTRAVENOUS, VOLTAREN, MUCOSTA. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5070528-2
Consumer or non-health professional from MEXICO reported TEGRETOL problem on July 27, 2006. Female patient, 37 years of age, was diagnosed with depression and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: restlessness. TEGRETOL dosage: 200 MG, QD. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5070530-0
TEGRETOL problem was reported by a Pharmacist from JAPAN on July 04, 2006. Male patient, 59 years of age, was diagnosed with subarachnoid haemorrhage and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: ammonia increased, blood alkaline phosphatase increased, hyperammonaemia. TEGRETOL dosage: 600 MG/DAY. During the same period patient was treated with PURSENNID, VALERIN, ARICEPT, ZONISAMIDE. Patient recovered.
Tegretol Side Effects Report #5070532-4
Consumer or non-health professional from GERMANY reported TEGRETOL problem on July 28, 2006. Male patient, 61 years of age, was diagnosed with epilepsy, pain and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: dizziness, grand mal convulsion, inguinal hernia, obstructive, pain, surgery, tinnitus, visual disturbance. TEGRETOL dosage: 400 MG, BID. During the same period patient was treated with VOLTAREN, KEPPRA, TAVOR. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5070533-6
TEGRETOL problem was reported by a Physician from JAPAN on May 29, 2006. Female patient was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: hyperprolactinaemia. TEGRETOL dosage: 200 MG/DAY. Patient recovered.
Tegretol Side Effects Report #5070538-5
Health Professional from SWITZERLAND reported TEGRETOL problem on July 28, 2006. Female patient, 42 years of age, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: periodontal destruction, periodontitis, surgery. TEGRETOL dosage: 800 MG/DAY. During the same period patient was treated with RIVOTRIL, KEPPRA, TRILEPTAL. Patient recovered.
Tegretol Side Effects Report #5070539-7
TEGRETOL problem was reported by a Physician from UNITED KINGDOM on July 25, 2006. Female patient was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: headache, intracranial pressure increased, vitamin a increased. TEGRETOL dosage: 1000MG/DAY. During the same period patient was treated with VITAMIN A. Patient recovered.
Tegretol Side Effects Report #5070541-5
Consumer or non-health professional from FRANCE reported TEGRETOL problem on July 10, 2006. Female patient, 38 years of age, was diagnosed with cluster headache and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: genital pruritus female, genital ulceration, lactobacillus infection, mouth ulceration, rash erythematous, rash maculovesicular, toxic skin eruption. TEGRETOL dosage: 500 MG, QD. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5070542-7
TEGRETOL problem was reported by a Consumer or non-health professional from BRAZIL on July 28, 2006. Female patient, 53 years of age, weighting 132.3 lb, was diagnosed with hypertension, hypothyroidism, vitamin supplementation, anxiety and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: acute abdomen, anxiety, cardiac arrest, cardiac failure congestive, cardiomegaly, cyst, cystitis, disorientation, multi-organ failure. TEGRETOL dosage: 200 MG, QID. During the same period patient was treated with CAPTOPRIL, EUTHYROX, BENERVA, OLCADIL, GARBAPENTIN. Patient was hospitalized. Patient died on 07/20/2006.
Tegretol Side Effects Report #5072067-1
Consumer or non-health professional from BRAZIL reported TEGRETOL problem on July 28, 2006. Female patient, 70 years of age, weighting 136.7 lb, was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: stroke in evolution, syncope. TEGRETOL dosage: 200 MG, BID. During the same period patient was treated with LEXOTAN, POLARAMINE. Patient recovered.
Tegretol Side Effects Report #5072069-5
TEGRETOL problem was reported by a Consumer or non-health professional from FRANCE on Aug 01, 2006. Male patient, 70 years of age, was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, meningoradiculitis, neutrophil count decreased, white blood cell count decreased. TEGRETOL dosage: 300 MG PER DAY. During the same period patient was treated with PRAZEPAM, VASTAREL, ASPIRIN. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5073263-X
Physician from CHINA reported TEGRETOL problem on June 25, 2006. Female patient, 61 years of age, was diagnosed with neuritis and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: blister, erythema, mucosal haemorrhage, platelet count decreased, pyrexia, rash papular, respiratory tract haemorrhage, skin hyperpigmentation. TEGRETOL dosage: 200 MG, BID. Patient recovered.
Tegretol Side Effects Report #5074831-1
TEGRETOL problem was reported by a Health Professional from SWEDEN on July 31, 2006. Female patient, 71 years of age, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, fatigue, gamma-glutamyltransferase increased, hepatic enzyme increased, pollakiuria, pyrexia, rash. TEGRETOL dosage: 600 MG/DAY. During the same period patient was treated with PULMICORT, TROMBYL. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5074832-3
Consumer or non-health professional from JAPAN reported TEGRETOL problem on July 26, 2006. Female patient, 41 years of age, was diagnosed with convulsion and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: cytomegalovirus viraemia, enteritis infectious, hepatocellular damage, human herpes virus 6 serology positive, multi-organ failure, rash, status epilepticus. TEGRETOL dosage: unknown. During the same period patient was treated with VALPROATE, ZONISAMIDE, PREDNISONE, PHENOBARBITAL, IMMUNOGLOBULIN G, STEROIDS NOS. Patient was hospitalized. Patient died.
Tegretol Side Effects Report #5074833-5
TEGRETOL problem was reported by a Physician from JAPAN on June 28, 2006. Female patient, 53 years of age, was diagnosed with temporal lobe epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: cerebral atrophy, computerised tomogram abnormal, convulsion, nuclear magnetic resonance imaging abnormal. TEGRETOL dosage: 300 MG/DAY. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5075632-0
Consumer or non-health professional from UNITED STATES reported TEGRETOL problem on Feb 07, 2006. Female patient, 35 years of age, was diagnosed with bipolar disorder and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: abdominal pain, alanine aminotransferase increased, anaemia, anal discomfort, bedridden, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, carbon dioxide decreased, cellulitis. TEGRETOL dosage: unknown. During the same period patient was treated with ATARAX, LORTAB, SYNTHROID, TRILEPTAL. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5076387-6
TEGRETOL problem was reported by a Health Professional from SWEDEN on July 31, 2006. Female patient, 32 years of age, was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: apathy, depressed level of consciousness, fatigue, intubation, poisoning. TEGRETOL dosage: 20000 MG, ONCE/SINGLE. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5078101-7
Physician from JAPAN reported TEGRETOL problem on July 03, 2006. Female patient, 60 years of age, weighting 99.21 lb, was diagnosed with trigeminal neuralgia and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, fatigue, gamma-glutamyltransferase increased, haematocrit decreased, haemoglobin decreased, malaise. TEGRETOL dosage: unknown. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5078857-3
TEGRETOL problem was reported by a Pharmacist from JAPAN on Aug 02, 2006. Male patient, 73 years of age, was diagnosed with temporal lobe epilepsy, hypertension and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: haemangioma, platelet count decreased, thrombocytopenia. TEGRETOL dosage: 200 MG/DAY. During the same period patient was treated with DIOVAN. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5078865-2
Consumer or non-health professional from UNITED KINGDOM reported TEGRETOL problem on Aug 30, 2005. Female patient, 79 years of age, was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: amnesia, cellulitis, confusional state, diarrhoea, faecal incontinence, malaise, urinary tract infection. TEGRETOL dosage: 600MG PER DAY. During the same period patient was treated with ERYTHROMYCIN, ATORVASTATIN CALCIUM, ADALAT SL, CARDURA CR, IRBESARTAN, FYBOGEL, RAMIPRIL. Patient recovered.
Tegretol Side Effects Report #5078868-8
TEGRETOL problem was reported by a Consumer or non-health professional from FRANCE on Aug 03, 2006. Female patient, 19 years of age, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: foetal growth retardation, oligohydramnios, placental disorder. TEGRETOL dosage: unknown. During the same period patient was treated with RUDIVAX. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5079299-7
Consumer or non-health professional from UNITED STATES reported TEGRETOL problem on Feb 07, 2006. Female patient, 35 years of age, was diagnosed with bipolar disorder and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: abdominal pain, alanine aminotransferase increased, anaemia, anal discomfort, bedridden, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, carbon dioxide decreased, cellulitis. TEGRETOL dosage: unknown. During the same period patient was treated with ATARAX, LORTAB, SYNTHROID, TRILEPTAL. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5079857-X
TEGRETOL problem was reported by a Physician from BRAZIL on Mar 31, 2006. Male patient, 25 years of age, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: bone density decreased, convulsion, fall, femur fracture, lower limb fracture. TEGRETOL dosage: unknown. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5079860-X
Consumer or non-health professional from UNITED STATES reported TEGRETOL problem on Mar 13, 2006. Female patient, 50 years of age, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: aplastic anaemia, depressed level of consciousness, intentional overdose, leukopenia, suicide attempt, thrombocytopenia. TEGRETOL dosage: unknown. During the same period patient was treated with KEPPRA, VALPROIC ACID, VALPROIC ACID, DILANTIN. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5079862-3
TEGRETOL problem was reported by a Physician from JAPAN on Aug 02, 2006. Male patient, 73 years of age, weighting 116.8 lb, was diagnosed with temporal lobe epilepsy, hypertension and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: haemangioma, platelet count decreased, thrombocytopenia. TEGRETOL dosage: 600 MG/DAY. During the same period patient was treated with DIOVAN. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5080422-9
Physician from UNITED STATES reported TEGRETOL problem on Aug 14, 2006. Female patient, 33 years of age, weighting 238.0 lb, was diagnosed with convulsion and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: headache, nausea, vomiting. TEGRETOL dosage: unknown. Patient recovered.
Tegretol Side Effects Report #5084160-8
TEGRETOL problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 15, 2006. Female patient, weighting 13.00 lb, was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: arnold-chiari malformation, atrial septal defect, dyspnoea, meningomyelocele, pulmonary artery stenosis congenital, respiratory distress, spina bifida, spine malformation. TEGRETOL dosage: unknown. During the same period patient was treated with COMBIVIR, VALPROATE, NELFINAVIR MESILATE, KALETRA, FOLIC ACID, METRONIDAZOLE, FLUCONAZOLE. Patient died on 12/30/2005.
Tegretol Side Effects Report #5084163-3
Consumer or non-health professional from UNITED STATES reported TEGRETOL problem on Mar 13, 2006. Female patient, 50 years of age, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: aplastic anaemia, depressed level of consciousness, intentional overdose, leukopenia, loss of consciousness, suicide attempt, thrombocytopenia. TEGRETOL dosage: unknown. During the same period patient was treated with KEPPRA, VALPROIC ACID, VALPROIC ACID, DILANTIN, DIVALPROEX. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5085075-1
TEGRETOL problem was reported by a Consumer or non-health professional from MEXICO on Aug 09, 2006. Female patient, 69 years of age, was diagnosed with neck pain and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: anorexia, depression, oedema. TEGRETOL dosage: 200 MG, BID. During the same period patient was treated with DICLOFENAC, VITAMIN B CAP. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5086183-1
Physician from GERMANY reported TEGRETOL problem on Aug 08, 2006. Female patient, 41 years of age, was diagnosed with dependence, pneumonia and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: coordination abnormal, disorientation, fall, haematoma, nystagmus, pneumonia, somnolence. TEGRETOL dosage: 400 MG ; 800 MG ; 400 MG. During the same period patient was treated with ERHTYROMYCIN, METRONIDAZOLE, DIAZEPAM, GABAPENTIN. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5086235-6
TEGRETOL problem was reported by a Pharmacist from UNITED KINGDOM on June 20, 2006. Female patient was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: poor weight gain neonatal. TEGRETOL dosage: unknown. Patient recovered.
Tegretol Side Effects Report #5089719-X
Pharmacist from UNITED KINGDOM reported TEGRETOL problem on Aug 17, 2006. Female patient was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: respiratory tract infection, somnolence. TEGRETOL dosage: unknown. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5089720-6
TEGRETOL problem was reported by a Pharmacist from JAPAN on July 04, 2006. Male patient, 59 years of age, was diagnosed with subarachnoid haemorrhage and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: ammonia increased, blood alkaline phosphatase increased, hyperammonaemia. TEGRETOL dosage: 600 MG/DAY. During the same period patient was treated with PURSENNID, VALERIN, ARICEPT, ZONISAMIDE. Patient recovered.
Tegretol Side Effects Report #5089721-8
Consumer or non-health professional from FRANCE reported TEGRETOL problem on Aug 16, 2006. Male patient, 84 years of age, was diagnosed with epilepsy, essential hypertension and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: aphasia, blood sodium decreased, c-reactive protein increased, carbon dioxide increased, cerebrovascular accident, disorientation, dysarthria. TEGRETOL dosage: 200 MG, BID. During the same period patient was treated with DEROXAT, PREVISCAN, CORTANCYL, AMLODIPINE BESYLATE, DEBRIDAT, DIFFU K. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5089722-X
TEGRETOL problem was reported by a Physician from GERMANY on Aug 22, 2006. Male patient was diagnosed with convulsion prophylaxis, hiv infection and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: asthenia, coordination abnormal, dizziness, nystagmus. TEGRETOL dosage: 800 MG/DAY. During the same period patient was treated with KALETRA, DIAZEPAM, FLUNITRAZEPAM. Patient recovered.
Tegretol Side Effects Report #5089724-3
Consumer or non-health professional from UNITED STATES reported TEGRETOL problem on Aug 15, 2006. Female patient, weighting 13.00 lb, was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: arnold-chiari malformation, atrial septal defect, dyspnoea, meningomyelocele, pulmonary artery stenosis congenital, respiratory distress, spina bifida, spine malformation. TEGRETOL dosage: unknown. During the same period patient was treated with COMBIVIR, VALPROATE, NELFINAVIR MESILATE, KALETRA, FOLIC ACID, METRONIDAZOLE, FLUCONAZOLE. Patient died on 12/30/2005.
Tegretol Side Effects Report #5089733-4
TEGRETOL problem was reported by a Physician from JAPAN on July 03, 2006. Female patient, 60 years of age, weighting 99.21 lb, was diagnosed with trigeminal neuralgia and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, fatigue, gamma-glutamyltransferase increased, haematocrit decreased, haemoglobin decreased, malaise. TEGRETOL dosage: unknown. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5090218-X
Consumer or non-health professional from UNITED STATES reported TEGRETOL problem on Aug 22, 2006. Male patient, 47 years of age, was diagnosed with depression and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: intentional overdose, suicide attempt. TEGRETOL dosage: unknown. During the same period patient was treated with KLONOPIN, RITALIN, METAGLIP, LIPITOR, TRILEPTAL. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5091056-4
TEGRETOL problem was reported by a Consumer or non-health professional from UNITED STATES on May 26, 2006. Female patient, 63 years of age, weighting 190.0 lb, was diagnosed with convulsion, nephrogenic anaemia, hypertension, diabetes mellitus, blood cholesterol increased and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: apraxia, carotid artery atheroma, carotid artery stenosis, convulsion, encephalomalacia, facial palsy, gait spastic, haemoglobin decreased, hyperreflexia. TEGRETOL dosage: 200 MG, BID. During the same period patient was treated with PROCRIT, AVAPRO, AVANDIA, PRAVACHOL, GLIPIZIDE. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5091067-9
Physician from UNITED STATES reported TEGRETOL problem on Apr 14, 2006. Male patient, 40 years of age, was diagnosed with neuropathy peripheral, swelling, fabry's disease, seasonal allergy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: abdominal pain, amnesia, angioneurotic oedema, arthralgia, depression, diarrhoea, dizziness, dyspnoea, hypoacusis. TEGRETOL dosage: unknown. During the same period patient was treated with FLONASE, ALLEGRA, CARBAMAZEPINE, LISINOPRIL, HYDROCHLOROTHIAZIDE, FABRAZYME, MAXIFED. Patient recovered.
Tegretol Side Effects Report #5093811-3
TEGRETOL problem was reported by a Pharmacist from UNITED KINGDOM on Aug 24, 2006. Female patient was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: incorrect dose administered. TEGRETOL dosage: 200 MG IN ERROR. Patient died on 07/01/2006.
Tegretol Side Effects Report #5093812-5
Pharmacist from UNITED KINGDOM reported TEGRETOL problem on Aug 22, 2006. Female patient was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, dysphagia. TEGRETOL dosage: 1600MG DAILY. During the same period patient was treated with PHENYTOIN. Patient recovered.
Tegretol Side Effects Report #5094880-7
TEGRETOL problem was reported by a Pharmacist from UNITED KINGDOM on Aug 24, 2006. Female patient was treated with TEGRETOL. TEGRETOL dosage: 200 MG IN ERROR. Patient died on 07/01/2006.
Tegretol Side Effects Report #5094948-5
Consumer or non-health professional from FRANCE reported TEGRETOL problem on June 14, 2006. Female patient, 79 years of age, weighting 114.6 lb, was diagnosed with neuralgia and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: face injury, fall, mouth injury, tooth disorder, traumatic haematoma. TEGRETOL dosage: 400 MG, QD. During the same period patient was treated with NOCTAMID, TRANXENE, DITROPAN, SECTRAL, DEROXAT, ASPIRIN, AMLODIPINE BESYLATE, CORTANCYL. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5095106-0
TEGRETOL problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 13, 2006. Female patient, 50 years of age, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: aplastic anaemia, depressed level of consciousness, intentional overdose, leukopenia, suicide attempt, thrombocytopenia. TEGRETOL dosage: unknown. During the same period patient was treated with KEPPRA, VALPROIC ACID, VALPROIC ACID, DILANTIN, DIVALPROEX. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5095107-2
Consumer or non-health professional from UNITED STATES reported TEGRETOL problem on Aug 15, 2006. Female patient, weighting 13.00 lb, was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: arnold-chiari malformation, atrial septal defect, dyspnoea, meningomyelocele, pulmonary artery stenosis congenital, respiratory distress, spina bifida, spine malformation. TEGRETOL dosage: unknown. During the same period patient was treated with COMBIVIR, VALPROATE, NELFINAVIR MESILATE, KALETRA, FOLIC ACID, METRONIDAZOLE, FLUCONAZOLE. Patient died on 12/30/2005.
Tegretol Side Effects Report #5097004-5
TEGRETOL problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 15, 2006. Female patient, child 8 years of age, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: circulatory collapse, epilepsy, hypertrophic cardiomyopathy, influenza, respiratory arrest. TEGRETOL dosage: 7.5MG DAILY. Patient died on 03/29/2005.
Tegretol Side Effects Report #5097007-0
Physician from PHILIPPINES reported TEGRETOL problem on Aug 31, 2006. Female patient was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: coma. TEGRETOL dosage: unknown. Patient recovered.
Tegretol Side Effects Report #5097009-4
TEGRETOL problem was reported by a Consumer or non-health professional from BRAZIL on Aug 25, 2006. Male patient, 33 years of age, weighting 114.6 lb, was diagnosed with epilepsy, depression, headache and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: anorexia, feeling abnormal, feeling hot, head discomfort, headache, malaise, mitral valve disease, restlessness, retching. TEGRETOL dosage: 400 MG, Q12H. During the same period patient was treated with HALIDOL, AKINETON, RIVOTRIL. Patient recovered.
Tegretol Side Effects Report #5098435-X
Consumer or non-health professional from BRAZIL reported TEGRETOL problem on Aug 28, 2006. Male patient, child 12 years of age, was diagnosed with petit mal epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: asthenia, disorientation, fatigue, learning disorder, memory impairment, nervous system disorder, petit mal epilepsy, somnolence. TEGRETOL dosage: 500 MG/DAY. Patient recovered.
Tegretol Side Effects Report #5098437-3
TEGRETOL problem was reported by a Health Professional from BRAZIL on Apr 20, 2006. Female patient, child 7 years of age, was diagnosed with cerebral disorder and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: dyspepsia, gastritis, somnolence, vomiting. TEGRETOL dosage: 5 ML, Q8H. Patient recovered.
Tegretol Side Effects Report #5098591-3
Consumer or non-health professional from GERMANY reported TEGRETOL problem on June 26, 2006. Female patient, weighting 154.3 lb, was diagnosed with partial seizures, hypertension and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: intraocular pressure increased, optic atrophy, visual disturbance, visual field defect. TEGRETOL dosage: 300 MG IN THE EVENING. During the same period patient was treated with BISOPROLOL FUMARATE, LEXOTANIL. Patient recovered.
Tegretol Side Effects Report #5098645-1
TEGRETOL problem was reported by a Pharmacist from JAPAN on Aug 29, 2006. Female patient, 65 years of age, was diagnosed with pain and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: incontinence, movement disorder. TEGRETOL dosage: 100 MG/DAY. During the same period patient was treated with HYPEN, VOLTAREN, FLUCAM. Patient recovered.
Tegretol Side Effects Report #5098646-3
Physician from FRANCE reported TEGRETOL problem on Aug 29, 2006. Male patient, 49 years of age, was diagnosed with aggression and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, dysarthria. TEGRETOL dosage: unknown. During the same period patient was treated with SOLIAN, TAHOR. Patient recovered.
Tegretol Side Effects Report #5099494-0
TEGRETOL problem was reported by a Consumer or non-health professional from BRAZIL on Aug 31, 2006. Male patient, 39 years of age, weighting 149.9 lb, was diagnosed with bipolar disorder and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: dental caries, fatigue, mental impairment, sexual dysfunction, sluggishness. TEGRETOL dosage: 200 MG, TID. Patient recovered.
Tegretol Side Effects Report #5099497-6
Physician from BRAZIL reported TEGRETOL problem on Aug 30, 2006. Female patient, 68 years of age, was diagnosed with convulsion and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: convulsion, cough, dyskinesia, nystagmus, tuberculosis, vertigo, vomiting. TEGRETOL dosage: 600 MG/DAY. During the same period patient was treated with LEXOTAN. Patient was hospitalized. Patient recovered.
Tegretol Side Effects Report #5101138-6
TEGRETOL problem was reported by a Physician from JAPAN on Sept 01, 2006. Female patient, 15 years of age, was diagnosed with convulsion and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: depressed level of consciousness, vomiting. TEGRETOL dosage: unknown. Patient recovered.
< Previous Showing 301-400 of 685 Next >
Drug Information: Carbamazepine
URL of this page: http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a682237.html
(kar ba maz' e peen)IMPORTANT WARNING:
| [Posted 01/31/2008] FDA informed healthcare professionals that the Agency has analyzed reports of suicidality (suicidal behavior or ideation) from placebo-controlled clinical studies of eleven drugs used to treat epilepsy as well as psychiatric disorders, and other conditions. In the FDA's analysis, patients receiving antiepileptic drugs had approximately twice the risk of suicidal behavior or ideation (0.43%) compared to patients receiving placebo (0.22%). The increased risk of suicidal behavior and suicidal ideation was observed as early as one week after starting the antiepileptic drug and continued through 24 weeks. The results were generally consistent among the eleven drugs. The relative risk for suicidality was higher in patients with epilepsy compared to patients who were given one of the drugs in the class for psychiatric or other conditions.Healthcare professionals should closely monitor all patients currently taking or starting any antiepileptic drug for notable changes in behavior that could indicate the emergence or worsening of suicidal thoughts or behavior or depression.The drugs included in the analyses include (some of these drugs are also available in generic form): Carbamazepine (marketed as Carbatrol, Equetro, Tegretol, Tegretol XR)Felbamate (marketed as Felbatol)Gabapentin (marketed as Neurontin) Lamotrigine (marketed as Lamictal) Levetiracetam (marketed as Keppra) Oxcarbazepine (marketed as Trileptal)Pregabalin (marketed as Lyrica) Tiagabine (marketed as Gabitril)Topiramate (marketed as Topamax) Valproate (marketed as Depakote, Depakote ER, Depakene, Depacon) Zonisamide (marketed as Zonegran) Although the 11 drugs listed above were the ones included in the analysis, FDA expects that the increased risk of suicidality is shared by all antiepileptic drugs and anticipates that the class labeling changes will be applied broadly. For more information visit the FDA website at: http://www.fda.gov/medwatch/safety/2008/safety08.htm#Antiepileptic and http://www.fda.gov/cder/drug/InfoSheets/HCP/antiepilepticsHCP.htm. |
IMPORTANT WARNING:
| Carbamazepine may cause life-threatening allergic reactions called Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN). These allergic reactions may cause severe damage to the skin and internal organs. The risk of SJS or TEN is highest in people of Asian ancestry who have a genetic (inherited) risk factor. If you are Asian, your doctor will usually order a test to see if you have the genetic risk factor before prescribing carbamazepine. If you do have this risk factor, your doctor will probably prescribe another medication that is less likely to cause SJS or TEN. If you do not have this genetic risk factor, your doctor may prescribe carbamazepine, but there is still a slight risk that you will develop SJS or TEN. Call your doctor immediately if you develop a rash, blisters, or a fever during your treatment with carbamazepine.Stevens-Johnson syndrome or toxic epidermal necrolysis usually occurs during the first few months of treatment with carbamazepine. If you have taken carbamazepine for several months or longer, you probably will not need to be tested, even if you are Asian.Carbamazepine may decrease the number of blood cells produced by your body. In rare cases, the number of blood cells may decrease enough to cause serious or life-threatening health problems. Tell your doctor if you have ever had a decreased number of blood cells, especially if it was caused by another medication. If you experience any of the following symptoms, call your doctor immediately: sore throat, fever, chills or other signs of infection; unusual bleeding or bruising; tiny purple dots or spots on the skin; mouth sores; or rash.Keep all appointments with your doctor and the laboratory. Your doctor will order certain lab tests before and during your treatment to check your body's response to carbamazepine. |
Why is this medication prescribed?
Carbamazepine is used alone or in combination with other medications to treat certain types of seizures in patients with epilepsy. It is also used to treat trigeminal neuralgia (a condition that causes facial nerve pain). Carbamazepine extended-release capsules (Equetro brand only) are used to treat episodes of mania (frenzied, abnormally excited or irritated mood) or mixed episodes (symptoms of mania and depression that happen at the same time) in patients with bipolar I disorder (manic depressive disorder; a disease that causes episodes of depression, episodes of mania, and other abnormal moods). Carbamazepine is in a class of medications called anticonvulsants. It works by reducing abnormal excitement in the brain.
How should this medicine be used?
Carbamazepine comes as a tablet, a chewable tablet, an extended-release (long-acting) tablet, an extended-release capsule, and a suspension (liquid) to take by mouth. The regular tablet, chewable tablet, and liquid are usually taken two to four times a day with meals. The extended-release tablet is usually taken twice a day with meals. The extended-release capsule is usually taken twice a day with or without meals. To help you remember to take carbamazepine, take it at around the same times every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take carbamazepine exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
Swallow the extended-release tablets whole; do not split, chew, or crush them. The extended-release capsules may be opened and the beads inside sprinkled over food, such as a teaspoon of applesauce or similar food. Do not crush or chew the extended-release capsules or the beads inside them.
Shake the liquid well before each use to mix the medication evenly.
Your doctor will start you on a low dose of carbamazepine and gradually increase your dose.
It may take a few weeks or longer before you feel the full benefit of carbamazepine. Continue to take carbamazepine even if you feel well. Do not stop taking carbamazepine without talking to your doctor. If you have a seizure disorder and you suddenly stop taking carbamazepine, your seizures may become worse. Your doctor will probably decrease your dose gradually.
Other uses for this medicine
Carbamazepine is also sometimes used to treat mental illnesses, depression, posttraumatic stress disorder, drug and alcohol withdrawal, restless legs syndrome, diabetes insipidus, certain pain syndromes, and a disease in children called chorea. Talk to your doctor about the possible risks of using this medication for your condition.
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
What special precautions should I follow?
Before taking carbamazepine,
- tell your doctor and pharmacist if you are allergic to carbamazepine, amitriptyline (Elavil), amoxapine (Asendin), clomipramine (Anafranil), desipramine (Norpramin), doxepin (Adapin, Sinequan), imipramine (Tofranil), nortriptyline (Aventyl, Pamelor), other medications for seizures such as phenobarbital (Luminal, Solfoton) or phenytoin (Dilantin), protriptyline (Vivactil), trimipramine (Surmontil), or any other medications.
- you should know that carbamazepine is the active ingredient in several products that have different names and may be prescribed to treat different conditions. Check the list of brand names at the beginning of this document carefully. All of the products listed contain carbamazepine and you should not take more than one of them at the same time.
- do not take carbamazepine if you are taking monoamine oxidase (MAO) inhibitors, including isocarboxazid (Marplan), phenelzine (Nardil) selegiline (Eldepryl); and tranylcypromine (Parnate), or have stopped taking them within the past 2 weeks.
- tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking. Be sure to mention any of the following: acetaminophen (Tylenol); acetazolamide (Diamox); alprazolam (Xanax); anticoagulants ('blood thinners') such as warfarin (Coumadin); antidepressants such as amitriptyline (Elavil), bupropion (Wellbutrin, Zyban), buspirone (BuSpar), citalopram (Celexa), clomipramine (Anafranil), desipramine (Norpramin), fluoxetine (Prozac, Sarafem), fluvoxamine (Luvox), mirtazapine (Remeron), nortriptyline (Pamelor); antifungals such as itraconazole (Sporanox) and ketoconazole (Nizoral); cimetidine (Tagamet); cisplatin (Platinol); clarithromycin (Biaxin); clonazepam (Klonopin); clozapine (Clozaril); cyclosporine (Neoral, Sandimmune); daltopristin and quinupristin (Synercid); danazol (Danocrine); delavirdine (Rescriptor);diltiazem (Cardizem, Dilacor, Tiazac); doxorubicin (Adriamycin, Rubex); doxycycline (Vibramycin); erythromycin (E.E.S., E-Mycin, Erythrocin); felodipine (Plendil); haloperidol (Haldol); HIV protease inhibitors including atazanavir (Reyataz), indinavir (Crixivan), lopinavir (in Kaletra), nelfinavir (Viracept), ritonavir (Norvir, in Kaletra), and saquinavir (Fortovase, Invirase); isoniazid (INH, Nydrazid); levothyroxine (Levoxyl, Synthroid); lithium (Lithobid); loratadine (Claritin); lorazepam (Ativan); certain medications to treat malaria such as chloroquine (Aralen) and mefloquine (Lariam); medications for anxiety or mental illness; other medications for seizures such as ethosuximide (Zarontin), felbamate (Felbatol), lamotrigine (Lamictal), methsuximide (Celontin), oxcarbazepine (Trileptal), phenobarbital (Luminal, Solfoton), phensuximide (Milontin) (not available in the United States), phenytoin (Dilantin), primidone (Mysoline), tiagabine (Gabitril), topiramate (Topamax), and valproic acid (Depakene, Depakote); methadone (Dolophine); nefazodone; niacinamide (nicotinamide, Vitamin B3); propoxyphene (Darvon); praziquantel (Biltricide); quinine; rifampin (Rifadin, Rimactane); sedatives; sleeping pills; terfenadine (Seldane) (not available in the United States); theophylline (Theobid, Theo-Dur); tramadol (Ultram); tranquilizers; troleandomycin (TAO); verapamil (Calan, Covera, Isoptin, Verelan); and zileuton (Zyflo). Many other medications may also interact with carbamazepine, so be sure to tell your doctor about all the medications you are taking, even those that do not appear on this list. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
- if you are taking any other liquid medications, do not take them at the same time as carbamazepine liquid.
- tell your doctor what herbal products you are taking, especially St. John's Wort.
- tell your doctor if you have or have ever had glaucoma; psychosis; or heart, kidney, thyroid, or liver disease.
- you should know that carbamazepine may decrease the effectiveness of hormonal contraceptives (birth control pills, patches, rings, injections, implants, or intrauterine devices). Use another form of birth control while taking carbamazepine. Tell your doctor if you have unexpected vaginal bleeding or think you may be pregnant while you are taking carbamazepine.
- tell your doctor if you are pregnant or plan to become pregnant. Carbamazepine may harm the fetus. If you become pregnant while taking carbamazepine, call your doctor immediately.
- Do not breastfeed while you are taking carbamazepine.
- if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking carbamazepine.
- you should know that carbamazepine may make you drowsy. Do not drive a car or operate machinery until you know how this medication affects you.
- remember that alcohol can add to the drowsiness caused by this medication.
What special dietary instructions should I follow?
Talk to your doctor about drinking grapefruit juice while taking this medicine.
What should I do if I forget a dose?
Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.
What side effects can this medication cause?
Carbamazepine may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
- drowsiness
- dizziness
- unsteadiness
- upset stomach
- vomiting
- headache
- anxiety
- memory problems
- diarrhea
- constipation
- heartburn
- dry mouth
- back pain
Some side effects can be serious. The following symptoms are uncommon, but if you experience any of them or those listed in the IMPORTANT WARNING section, call your doctor immediately:
- confusion
- loss of contact with reality
- depression
- thinking about killing yourself or planning or trying to do so
- chest pain
- yellowing of the skin or eyes
- vision problems
Carbamazepine may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online [at http://www.fda.gov/MedWatch/index.html] or by phone [1-800-332-1088].
What storage conditions are needed for this medicine?
Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature, away from excess heat and moisture (not in the bathroom). Throw away any medication that is outdated or no longer needed. Talk to your pharmacist about the proper disposal of your medication.
In case of emergency/overdose
In case of overdose, call your local poison control center at 1-800-222-1222. If the victim has collapsed or is not breathing, call local emergency services at 911.
Symptoms of overdose may include:
- unconsciousness
- seizures
- restlessness
- muscle twitching
- abnormal movements
- shaking of a part of your body that you cannot control
- unsteadiness
- drowsiness
- dizziness
- blurred vision
- irregular or slowed breathing
- rapid or pounding heartbeat
- upset stomach
- vomiting
- difficulty urinating
What other information should I know?
Before having any laboratory test, tell your doctor and the laboratory personnel that you are taking carbamazepine.
Carbamazepine can interfere with the results of home pregnancy tests. Talk to your doctor if you think you might be pregnant while you are taking carbamazepine. Do not try to test for pregnancy at home.
The extended-release tablet does not dissolve in the stomach after swallowing. It slowly releases the medicine as it passes through your digestive system. You may notice the tablet coating in the stool.
Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
Brand name(s):
|
|
|
Ask Our Patient Community about Tegretol |
||
|
|
||
|
|
||